Ecopia and Caprion pool resources
Caprion and Ecopia have agreed to merge as equals to form an as yet unnamed public entity with three programs in cancer and infectious diseases in clinical development.
Archives for January 8, 2007
Generics sale on the cards as Merck Serono starts dealing
Merck KGaA last week confirmed that it is considering selling off its generics division, prompting mass speculation over potential buyers within the industry.
Melbourn Scientific expands parenteral testing capacity
Melbourn Scientific has invested in a light obscuration particle counter to size and count particles in liquid samples using light microscopy, to expand the company's capacity in stability testing and to increase throughput and efficiency.
Genentech's cancer drug 'encouraging'
There may yet be a positive outcome to Genetech's once-failing cancer drug, after the company announced "encouraging" Phase II trial results.
Scientists win patent for nanotech manufacturing process
US researchers have been awarded a patent for their new manufacturing technology which enables the quick and cheap production of nanoparticles used to formulate and deliver drugs - good news for NanoMed who has an exclusive licence for the technology.
Ethical Stem Cell Source
Scientists have discovered stem cells in the amniotic fluid that surrounds the foetus in pregnant women, bypassing ethical concerns over the source of the versatile cells.
Tufts optimistic for drug development
Despite the many challenges facing the pharmaceutical industry, drug developers should be optimistic, according to a report from the Tufts Center for the Study of Drug Development (CSDD).
Merck & Co increases vaccine manufacturing capacity in Durham
Drug maker Merck & Co has entered an expansion phase, to boost global manufacturing capacity for vaccines, adding $100 million to its facilities in Durham.
Janssen's Invega approved for schizophrenia
The US Food and Drug Administration (FDA) has approved Janssen's new drug Invega (paliperidone); the first new prescription drug for the treatment of schizophrenia since 2003.